Doctor profile · Federal record
Dr. JOHN RUGGIANO, M.D.
Psychiatry Physician · CRANSTON, RI
- NPI 1609844240
- 20 yrs on file
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1090 NEW LONDON AVE
CRANSTON, RI 029203035
(401) 463-5778
fax (401) 463-3582
Credentials & registration
- NPI registered
- March 2006 — 20 yrs on file
- Profile last updated
- December 18, 2007
- Specialty taxonomy
- 2084P0800X — NUCC code
- State license (1)
- Rhode Island #MD04335
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1609844240. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
577
Distinct HCPCS
5
Medicare allowed
$50,447
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
90833 |
Psychotherapy with evaluation and management visit, 30 minutes | 248 | 61 | $64 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 183 | 57 | $118 | |
99443 |
Telephone medical discussion with physician, 21-30 minutes | 64 | 27 | $124 | |
G2012 |
Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic | 62 | 26 | $14 | |
99205 |
New patient office or other outpatient visit, 60-74 minutes | 20 | 20 | $214 |
In context: peer comparison
Among 9 peers in this city , average services per provider: 88. This provider delivers 6.6× the peer median.Open Payments
Industry payments received
All-time total
$1,903
Transactions
66
Manufacturers
10
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Vanda Pharmaceuticals Inc. | 12 | $606.38 | |
| Supernus Pharmaceuticals, Inc. | 2 | $380.43 | |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $332.90 | |
| Otsuka America Pharmaceutical, Inc. | 19 | $214.46 | |
| Neurocrine Biosciences, Inc. | 4 | $93.43 | |
| Lundbeck LLC | 5 | $81.44 | |
| Alkermes, Inc. | 3 | $66.34 | |
| ABBVIE INC. | 3 | $64.77 | |
| Teva Pharmaceuticals USA, Inc. | 2 | $41.91 | |
| Janssen Pharmaceuticals, Inc | 1 | $20.70 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
1,504
Patients
290
Total drug cost
$29,507
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Quetiapine Fumarate | Generic | 290 | 53 | $5,655 |
| Lamotrigine | Generic | 262 | 61 | $4,193 |
| Trazodone Hcl | Generic | 137 | 28 | $2,103 |
| Sertraline Hcl | Generic | 132 | 25 | $2,148 |
| Bupropion Xl (Bupropion Hcl) | Brand | 110 | 26 | $4,236 |
| Venlafaxine Hcl Er (Venlafaxine Hcl) | Brand | 80 | 14 | $3,035 |
| Buspirone Hcl | Generic | 78 | 15 | $2,056 |
| Clonazepam | Generic | 70 | 0 | $347 |
| Fluoxetine Hcl | Generic | 62 | 14 | $1,003 |
| Bupropion Hcl Sr (Bupropion Hcl) | Brand | 53 | 17 | $973 |